LAP3 and metabolic dysfunction-associated steatotic liver disease: Further, we observed an increased expression of LAP3 (involved in glutathione metabolism), a target that has previously found to be positively correlated with fasting blood glucose levels and has, by inhibiting autophagy, been implicated in the progression of Non-Alcoholic Fatty Liver Disease [90].